Security
Keros Therapeutics, Inc. Common Stock · KROS
KROSNASDAQCommon stockCurrentCIK 1664710Updated Oct 6, 2026
KROS price & chart
Loading TradingView…
NASDAQ:KROS on TradingView ↗In the news
Keros Therapeutics Appoints Anne Prener to its Board of Directors ↗
ADAR1 Announces ISS Recommends Keros Therapeutics Stockholders WITHHOLD Votes from Directors Dr. Mary Ann Gray and Dr. Alpna Seth News provided by ADAR1 Capital Management LLC May 21, 2025, 08:00 ET Share this article Share to X Share this article Share to X ADAR1 Urges Board to Release Strategic Re ↗
ADAR1 Capital Management Issues Open Letter to Keros Therapeutics Stockholders News provided by ADAR1 Capital Management LLC May 08, 2025, 14:10 ET Share this article Share to X Share this article Share to X Announces Intention to Withhold Votes for Directors Dr. Mary Ann Gray and Dr. Alpna Seth AUS ↗
Recent filings
Regulation FD Disclosure
Items 7.01, 9.01
Regulation FD Disclosure
Items 7.01, 9.01
EFFECT filing
DEL AM filing
S-3 filing
Show 5 more recent filings
Other Events
Items 8.01, 9.01
4 filing
Regulation FD Disclosure
Items 7.01, 9.01
10-Q filing
Results of Operations and Financial Condition
Items 2.02, 9.01
Financials
FY 2025 · USDSource
Source
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 338,021,000Source | 615,886,000Source | 370,025,000Source | 306,781,000Source |
| Property, Plant and Equipment, NetUSD | 4,297,000Source | 4,237,000Source | 4,134,000Source | 2,021,000Source |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 287,415,000Source | 559,931,000Source | 331,147,000Source | 279,048,000Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 3,567,000Source | 2,742,000Source | 143,000Source | 0Source |
| Assets, CurrentUSD | 315,434,000Source | 588,893,000Source | 347,293,000Source | 285,767,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 22,202,000Source | 26,220,000Source | 16,003,000Source | 6,719,000Source |
| Operating Lease, Right-of-Use AssetUSD | 16,841,000Source | 19,251,000Source | 15,334,000Source | 15,548,000Source |
| Other Assets, NoncurrentUSD | 0Source | 2,056,000Source | 2,052,000Source | 2,118,000Source |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 34,889,000Source | 44,333,000Source | 37,812,000Source | 29,358,000Source |
| Stockholders’ equity: | ||||
| Preferred Stock, Value, IssuedUSD | 0Source | 0Source | 0Source | 0Source |
| Common Stock, Value, IssuedUSD | 4,000Source | 4,000Source | 3,000Source | 2,000Source |
| Additional Paid in CapitalUSD | 1,169,451,000Source | 1,140,328,000Source | 713,636,000Source | 505,855,000Source |
| Retained Earnings (Accumulated Deficit)USD | -481,765,000Source | -568,779,000Source | -381,426,000Source | -228,434,000Source |
| Stockholders' Equity Attributable to ParentUSD | 303,132,000Source | 571,553,000Source | 332,213,000Source | 277,423,000Source |
| Liabilities and EquityUSD | 338,021,000Source | 615,886,000Source | 370,025,000Source | 306,781,000Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 20,414,000Source | 27,450,000Source | 24,373,000Source | 16,547,000Source |
| Operating Lease, Liability, CurrentUSD | 2,408,000Source | 1,978,000Source | 1,005,000Source | 455,000Source |
| Accounts Payable, CurrentUSD | 1,967,000Source | 4,602,000Source | 5,450,000Source | 3,339,000Source |
| Operating Lease, Liability, NoncurrentUSD | 14,475,000Source | 16,883,000Source | 13,439,000Source | 12,811,000Source |
| Additional Financial Items | ||||
| Accrued Liabilities, CurrentUSD | 16,039,000Source | 20,870,000Source | 17,918,000Source | 12,753,000Source |
cash flow · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Share-based Payment Arrangement, Noncash ExpenseUSD | 28,696,000Source | 34,872,000Source | 28,763,000Source | 18,682,000Source |
| Changes in operating assets and liabilities: | ||||
| Increase (Decrease) in Accounts ReceivableUSD | 825,000Source | 2,599,000Source | 143,000Source | -18,000,000Source |
| Increase (Decrease) in Accounts PayableUSD | -3,001,000Source | -249,000Source | 1,614,000Source | -408,000Source |
| Deferred Income Tax Expense (Benefit)USD | 0Source | 0Source | 0Source | 0Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | 107,505,000Source | -160,869,000Source | -124,508,000Source | -70,062,000Source |
| Cash flows from investing activities: | ||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | -1,551,000Source | -1,931,000Source | -2,464,000Source | -1,241,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | 1,551,000Source | 1,931,000Source | 2,464,000Source | 1,241,000Source |
| Cash flows from financing activities: | ||||
| Payments for Repurchase of Common StockUSD | 375,000,000Source | — | — | — |
| Net Cash Provided by (Used in) Financing ActivitiesUSD | -378,470,000Source | 391,821,000Source | 178,956,000Source | 120,309,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | -272,516,000Source | 229,021,000Source | 51,984,000Source | 49,006,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 288,864,000Source | 561,380,000Source | 332,359,000Source | 280,375,000Source |
| Supplemental disclosure of cash flow information: | ||||
| Income Taxes Paid, NetUSD | 7,145,000Source | — | — | — |
| Additional Financial Items | ||||
| Share-based Payment Arrangement, ExpenseUSD | 28,696,000Source | 34,872,000Source | 28,763,000Source | 18,682,000Source |
| DepreciationUSD | 1,509,000Source | 1,229,000Source | 815,000Source | 674,000Source |
| Depreciation, NonproductionUSD | 1,500,000Source | 1,200,000Source | 800,000Source | 700,000Source |
| Gain (Loss) on Disposition of Property Plant EquipmentUSD | 13,000Source | 0Source | -4,000Source | -12,000Source |
| General and Administrative ExpenseUSD | 46,849,000Source | 40,754,000Source | 34,834,000Source | 27,525,000Source |
| Income Tax Expense (Benefit)USD | 4,883,000Source | 300,000Source | 0Source | 0Source |
| Net Income (Loss) Attributable to ParentUSD | 87,014,000Source | -187,353,000Source | -152,992,000Source | -104,679,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | 87,014,000Source | -187,353,000Source | -152,992,000Source | -104,679,000Source |
| Nonoperating Income (Expense)USD | 24,328,000Source | 23,780,000Source | 16,949,000Source | 10,111,000Source |
| Operating ExpensesUSD | 176,492,000Source | 214,383,000Source | 170,092,000Source | 114,790,000Source |
| Other Nonoperating Income (Expense)USD | -539,000Source | -954,000Source | -206,000Source | 3,031,000Source |
| Proceeds from Stock Options ExercisedUSD | 150,000Source | 12,141,000Source | 3,225,000Source | 818,000Source |
income statement · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Total RevenueUSD | 244,061,000Source | 3,550,000Source | 151,000Source | 0Source |
| Operating Income (Loss)USD | 67,569,000Source | -210,833,000Source | -169,941,000Source | -114,790,000Source |
| Other Nonoperating Income (Expense)USD | -539,000Source | -954,000Source | -206,000Source | 3,031,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | 91,897,000Source | -187,053,000Source | -152,992,000Source | -104,679,000Source |
| Income Tax Expense (Benefit)USD | 4,883,000Source | 300,000Source | 0Source | 0Source |
| Net Income (Loss) Attributable to ParentUSD | 87,014,000Source | -187,353,000Source | -152,992,000Source | -104,679,000Source |
| Earnings Per Share, BasicUSD per share | 2.34Source | -5Source | -5.2Source | -4.15Source |
| Earnings Per Share, DilutedUSD per share | 2.3Source | -5Source | -5.2Source | -4.15Source |
| Weighted Average Number of Shares Outstanding, Basicshares | 37,221,211Source | 37,437,652Source | 29,447,119Source | 25,241,030Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 37,859,106Source | 37,437,652Source | 29,447,119Source | 25,241,030Source |
| Additional Financial Items | ||||
| Current Income Tax Expense (Benefit)USD | 4,883,000Source | 300,000Source | 0Source | 0Source |
| General and Administrative ExpenseUSD | 46,849,000Source | 40,754,000Source | 34,834,000Source | 27,525,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD | 74,804,000Source | -189,315,000Source | -156,571,000Source | -112,240,000Source |
| Interest Expense, DebtUSD | — | 0Source | 0Source | 1,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | 87,014,000Source | -187,353,000Source | -152,992,000Source | -104,679,000Source |
| Nonoperating Income (Expense)USD | 24,328,000Source | 23,780,000Source | 16,949,000Source | 10,111,000Source |
| Operating ExpensesUSD | 176,492,000Source | 214,383,000Source | 170,092,000Source | 114,790,000Source |
| Research and Development ExpenseUSD | 129,643,000Source | 173,629,000Source | 135,258,000Source | 87,265,000Source |